| 000 | 01918 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250515171952.0 | ||
| 264 | 0 | _c20100615 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1468-2060 | ||
| 024 | 7 |
_a10.1136/ard.2009.108027 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Tuyl, Lilian H D | |
| 245 | 0 | 0 |
_aSurvival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cMay 2010 |
||
| 300 |
_a807-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdiagnostic imaging |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEpidemiologic Methods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisolone _xadverse effects |
| 650 | 0 | 4 | _aRadiography |
| 650 | 0 | 4 |
_aSulfasalazine _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBoers, Maarten | |
| 700 | 1 | _aLems, Willem F | |
| 700 | 1 | _aLandewé, Robert B | |
| 700 | 1 | _aHan, Huub | |
| 700 | 1 | _avan der Linden, S | |
| 700 | 1 | _avan de Laar, Mart | |
| 700 | 1 | _aWesthovens, Rene | |
| 700 | 1 | _avan Denderen, J Christiaan | |
| 700 | 1 | _aWestedt, Marie-Louise | |
| 700 | 1 | _aPeeters, André J | |
| 700 | 1 | _aJacobs, Piet | |
| 700 | 1 | _aHuizinga, Tom W J | |
| 700 | 1 | _avan de Brink, Hans | |
| 700 | 1 | _aDijkmans, Ben A C | |
| 700 | 1 | _aVoskuyl, Alexandre E | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 69 _gno. 5 _gp. 807-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.2009.108027 _zAvailable from publisher's website |
| 999 |
_c18878108 _d18878108 |
||